New partner for the law firm Advant Beiten based in Hamburg: he’s Oliver Korte (50), joined the firm in October and comes from SKW Schwarz, where he headed the commercial practice. At Advant Beiten, he
The initial public offering of the sandal manufacturer Birkenstock, which had been eagerly awaited for months, was initially unsuccessful in terms of the share price. On the first day of trading on Wall Street, the
The first bond issued by a German company on a large scale under the Electronic Securities Act is worth three billion euros. The issuer is Deutsche Börse, which chose the digital issuing platform D7.
The chemical company BASF has spun off its exhaust catalyst and precious metal services businesses into an independent unit. The new company – focusing on the circular and hydrogen economy – falls under the name BASF Environmental
Listed construction group Strabag has initiated various capital measures to push the shareholding of sanctioned Russian oligarch Oleg Deripaska to below 25 per cent. At the same time, proceedings are underway at the Klagenfurt Regional Court
Ruag, the Swiss company active in the fields of aerospace and defence, escaped a multi-million fine. On the opposite, the German company Diehl, partner of the German Bundeswehr and international armed forces, has to pay
The software group SAP intends to take over the Bonn-based software management company LeanIX, specialised in so-called Enterprise Architecture Management (EAM), which is used by many law firms in Germany to flank their digitalisation processes.
The Augsburg-based arms manufacturer Renk is planning a return to the stock exchange before the end of October. Citigroup, Deutsche Bank and J.P. Morgan are leading the IPO. Commerzbank, Goldman Sachs, Landesbank Baden-Württemberg
Clear words were spoken at the Corporate Lawyers’ Congress (Unternehmensjuristenkongress) held in Berlin between September 13 and 15: the participants demanded a reduction of bureaucracy and regulation because, as it’s been explained, the tasks of the
German immunotherapy and pharmaceutical company BioNTech and its US partner Pfizer, producers of one of the Covid-19 vaccines, are trying to invalidate two patents owned by their competitor Moderna in front of the US Patent
